Future Science Group
Browse
Infographic_fon-2021-1006.pdf (2.18 MB)

Infographic – Summary of the CaboPoint study

Download (2.18 MB)
figure
posted on 2021-12-20, 14:30 authored by Laurence Albiges, Manuela Schmidinger, Naila Taguieva-Pioger, David Perol, Viktor Grünwald, Eric Guemas
CaboPoint: a Phase II study of cabozantinib as second-line treatment in patients with metastatic renal cell carcinoma

Funding

Ipsen

History